Competitor Analysis availables at pipeline stores

Newsletters

Weekly newsletter focused on antibodies, proteins & peptides, gene therapy, RNA and cell therapy, vaccines, biogenerics and related business. It contains brief abstracts of preclinical & clinical studies, regulatory updates and company news of the previous week, but for biologics only. Subscribe Now

Consultancy

Need consultancy on this topic? La Merie SL provides consultancy services to all clients who wish a fully personal, individual, strictly confidential and exclusive collaboration on a specific subject.

Thrombopoiesis-Stimulating Agents (TPO)

 

Product description

Competitor Analysis availables at Pipelinereview.com

Need consultancy on this topic?

The Competitive Intelligence Report Thrombopoiesis Stimulating Agents (ESA) as of August 2008 in its 4th edition provides information on thrombopoiesis stimulating agents on the market and in development which includes seven clinical stage new molecules in various indications from the product categories antibody, protein, peptide and small molecule (NCE). Thrombopoiesis stimulating agents are under evaluation for treatment of idiopathic thrombocytopenic purpura (ITP) and for prevention of severe thrombocytopenia induced by chemotherapy. Marketed products and development projects are listed in a tabular format providing Information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product category/Therapeutic Area,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

Index

  • Marketed products
  • Development projects
  • Discontinued projects

 

Buy now a Competitor Analysis on:
Thrombopoietin (TPO)